Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Gallium
EC Number:
231-163-8
EC Name:
Gallium
Cas Number:
7440-55-3
Molecular formula:
Ga
IUPAC Name:
gallium
Test material form:
solid: bulk

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Cell source:
foreskin from a single donor
Vehicle:
unchanged (no vehicle)
Amount/concentration applied:
Gallium (CAS No. 7440-55-3; EC No. 231-163-8) was warmed to 37°C and was applied as liquid test item topically undiluted to the model skin surface. 30 μL of test item were applied to the skin model and uniformly covered the skin surface with an area of 0.63 cm2.
Duration of treatment / exposure:
The whole exposure period for the used EpiDermTM skin model was 60 minutes. The incubation conditions were 37°C, 5% CO2 and 95% relative humidity for the first 35 minutes followed by 25 minutes at room temperature under a sterile hood.
Duration of post-treatment incubation (if applicable):
At the end of the exposure period, the test item was carefully washed from the skin surface with Dulbecco's phosphate buffered saline (D-PBS). Viability measurements were not performed immediately after the exposure to the test item, but after a post- treatment incubation period of the rinsed tissues in fresh assay medium of 42 hours. This period allows both for recovery from weakly irritant effects and for appearance of clear cytotoxic effects.
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
mean value for 3 replicates
Value:
111.3
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Remarks:
The mean optical density (OD) of 3 negative control tissues was 1.314 and was well within the acceptable range of ≥ 1.0 to ≤ 2.5.
Positive controls validity:
valid
Remarks:
The viability of cells treated with the positive reference item, 5% SDS, was 6.9% of the negative control and fulfilled the acceptance criterion of ≤ 20%.
Remarks on result:
no indication of irritation
Remarks:
The standard deviation determined for all triplicates was below the limit of acceptance of 18%.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the present test conditions, Gallium (CAS No. 7440-55-3; EC No. 231-163- 8) tested at an exposure time of 60 minutes and a 42-hour post-treatment incubation period, was non-cytotoxic and, hence, predicted to be non-irritant to skin in an experiment employing an artificial three-dimensional model of human skin. Hence, the test item did not show irritant properties and is therefore not classified as irritant (UN GHS no category).